Real-life assessment of CEUS LI-RADS using Sonazoid in focal liver lesions in cirrhotic patients: a prospective multicenter study

Real-life assessment of CEUS LI-RADS using Sonazoid in focal liver lesions in cirrhotic patients: a prospective multicenter study - Real-life assessment of CEUS LI-RADS using Sonazoid in focal liver lesions in cirrhotic patients: a prospective multicenter study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051408

Enrollment

500

Registered

2023-08-01

Start date

2023-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Focal liver lesions in patients with hepatitis B or hepatic cirrhosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Focal liver lesions in patients with hepatitis B or hepatic cirrhosis Patients received CEUS exmamination

Exclusion criteria

Exclusion criteria: Patients who has the history of egg allergy Patients who has the history of Sonazoid allergy Patients aged less than 18 year old

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy of original CEUS LI-RADS using Sonazoid for focal liver lesions including hepatocellular carcinoma	—

Countries

Japan,Asia(except Japan)

Contacts

Public ContactYasunori Minami

Kindai University Faculty of Medicine Department of Gastroenterology and Hepatology

minkun@med.kindai.ac.jp072-366-0221

Outcome results